On-Demand CME/CE

Preventing and Managing RSV Disease and Influenza Disease
in Your Pediatric Practice: Update

Web Based On-Demand Activity

The Pediatric Respiratory Care Initiative^™ (PRCI^®) is pleased to present this interactive CME/CE On-Demand Activity presented by

FACULTY

Jaime E. Fergie, MD
Associate Professor of Pediatrics
Texas A&M University College of Medicine
College Station, Texas

Jay M. Lieberman, MD
Professor of Clinical Pediatrics
University of California, Irvine,
School of Medicine
Orange, California

PLANNING COMMITTEE

Robert B. Belshe, MD-Co-Chair
Dianna and J. Joseph Adorjan Endowed
Chair of Infectious Diseases
and Immunology
Professor of Internal Medicine, Pediatrics, and
Molecular Microbiology
Saint Louis University School of Medicine
St. Louis, Missouri

Stan L. Block Jr, MD
Professor of Clinical Pediatrics
University of Louisville Medical School
Louisville, Kentucky
Professor of Clinical Pediatrics
University of Kentucky College of Medicine
Lexington, Kentucky

Caroline B. Hall, MD
Professor of Pediatrics and Medicine
University of Rochester School of Medicine
and Dentistry
Rochester, New York

Thuy N. Nguyen, PharmD-Co-Chair
Neonatal Clinical Specialist
Seton Family of Hospitals
Dell Children's Medical Center
of Central Texas
Austin, Texas

Robert C. Welliver Sr, MD-Co-Chair
Professor of Pediatrics
State University of New York at
Buffalo School of Medicine and
Biomedical Sciences
Buffalo, New York

FACULTY FINANCIAL DISCLOSURES

Faculty were asked to disclose whether they have any relevant financial relationships occurring within the past 12 months with a commercial interest.

Dr Belshe has indicated that he receives grant/research support from Merck & Co., Inc.; is a retained consultant for MedImmune, Inc. and Novartis Pharmaceuticals; and is a member of the speakers bureau for MedImmune, Inc., Merck & Co., Inc., and sanofi-aventis.

Dr Block indicated that he receives grant/research support from GlaxoSmithKline, MedImmune, Inc., Merck & Co., Inc., Novartis Pharmaceuticals, and sanofi-aventis; he is a retained consultant and is a member of the speakers bureau for MedImmune, Inc., Merck & Co., Inc., and sanofi aventis.

Dr Fergie has indicated that he receives grant/research support from MedImmune, Inc.; is a member of the speakers bureau for MedImmune, Inc. and sanofi pasteur; and is a member of the advisory board for MedImmune, Inc.

Dr Hall has indicated that she receives grant/research support from and is an ad hoc consultant and a member of the advisory board for MedImmune, Inc.

Dr Lieberman has indicated that he is an employee of Quest Diagnostics.

Dr Nguyen has indicated that she has no relevant financial relationships to disclose.

Dr Welliver has indicated that he receives grant/research support from Symphogen; is a member of the speakers bureau for MedImmune, Inc.; is an ad hoc consultant for Alnylam Pharmaceuticals, Inc. and MedImmune, Inc.; receives clinical trial support from MedImmune, Inc.; and received a Fellowship Award from MedImmune Inc..

PROFESSIONAL POSTGRADUATE SERVICES^® STAFF

Karla Castro, Program Director; Grace L. McBride, Senior Managing Editor; Mark Palangio, Senior Medical Writer; Theresa Setteducato, Senior Program Director; Lisa Cariaga, Program Director; Caroline Tredway, Vice President, Editorial; and Wadee'ah Terry, CME Program Manager, have indicated that they have no relevant financial relationships to disclose.

This interactive CME/CE On-Demand Activity has been peer reviewed by CME Peer Review, LLC, which has no relevant financial relationships to disclose.

ACTIVITY INFORMATION

Updated! Current Strategies in the Prevention and Management of RSV

New! ACIP Guidelines on Seasonal Influenza Vaccinations for Pediatric Patients

These educational activities are archived recordings of live webcasts that originally took place on October 1, 2008, and October 2, 2008.

Audience

This educational activity is designed for pediatricians, pharmacists, nurse practitioners, and other healthcare professionals involved in the care and management of pediatric respiratory patients.

Learning Objectives

After participating in this activity, participants should be able to

• - Identify the clinical presentation of respiratory syncytial virus (RSV) infection in premature infants and high-risk infants who present with the signs and symptoms, as described by the 2006 Clinical Practice Guidelines issued by the American Academy of Pediatrics (AAP)
• - Identify the risk factors for severe RSV infection
• - Describe the approaches for prevention of RSV infection and discuss the appropriate indications for prophylaxis
• - Describe the strategies for influenza prevention and identify the current vaccination recommendations for the 2008-09 season, as described by the Advisory Committee on Immunization Practices (ACIP)
• - Identify risk factors for influenza complications in children
• - Provide a rationale for current therapeutic strategies with live and killed vaccines and discuss the appropriate use of antiviral drugs

Sponsor

This educational activity is conducted as a part of the Pediatric Respiratory Care Initiative^TM (PRCI®), sponsored by Professional Postgraduate Services®, Secaucus, NJ.

CME/CE Credit

Professional Postgraduate Services^® designates this educational activity for a maximum of 2.0 AMA PRA Category 1 Credit^™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Albany College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Each of these programs, ACPE #045-999-08-030-L01-P for RSV and ACPE #045-999-08-031-L01-P for Influenza, has been designated for 1 contact hour for a total of 2 CEU.

Each of these programs has been approved for 1 contact hours of continuing education by the American Academy of Nurse Practitioners. Participants must complete both sections in order to receive credit. Identify this activity by using the following ID numbers:
RSV Program ID-0808376
Influenza Program ID-0808375

This on-demand educational activity offers continuing medical education (CME), continuing pharmacy education, and continuing nurse practitioner contact hours. Participants who wish to receive the appropriate credit for this educational activity should do the following: (1) view the on-demand programs; and (2) complete the post-test and evaluation form.

Participants have the ability to download their CME credit certificate upon the completion of the program. Statement of credit for continuing pharmacy education and continuing nurse practitioner credit will be mailed within 6 to 8 weeks.

Grantor

The Pediatric Respiratory Care Initiative^™ (PRCI^®) and this educational activity are supported by an educational grant from MedImmune, Inc.

DISCLOSURES

These educational activities are intended to provide current information on issues concerning RSV and influenza. Some of the information presented about the agents mentioned may include discussion of off-label or investigational, non-FDA-approved uses. Please refer to each manufacturer's full prescribing information before prescribing any of the agents mentioned in these activities. Please note: slides in the publication that include discussion of off-label or investigational uses are identified with the symbol .

Copyright © 2008 Professional Postgraduate Services^®. All rights reserved.

This activity may not be reproduced in whole or in part without the express written permission of Professional Postgraduate Services^®.

Pediatric Respiratory Care Initiative and PRCI are trademarks used herein under license.

Release date: December 22, 2008
Expiration date: December 22, 2009

Method of Participation
1) Complete both CME/CE On-Demand Programs
2) Complete the post-test
3) Complete the Evaluation form
4) Print or download the CME certificate

Note: Statement of credit for continuing pharmacy education and continuing nurse practitioner credit will be mailed within 6 to 8 weeks.

To view this program online, the following technology is recommended:

WINDOWS PC SYSTEM REQUIREMENTS:
266-MHz Pentium II; Windows 98; 64 MB RAM; 800 x 600 screen resolution set for "High Color (16-Bit)"; speakers; 16-Bit SoundBlaster or SoundBlaster-compatible sound card; Macromedia Flash player 6 or higher.

MACINTOSH^® SYSTEM REQUIREMENTS:
Power Mac G3 at 300 MHz; System 8.5 or higher (excluding Mac OSX); 96 MB RAM; 20 MB minimum hard disk space available; 800 x 600 screen resolution set to "Thousands of Colors"; Macromedia Flash player 6 or higher.

Influenza:

RSV: